Title

A Cross-Sectional Study of Growth and Metabolic Bone Disease in a Pediatric Global Cohort Undergoing Chronic Hemodialysis.

Authors

Rasha Hussein
Ana Catalina Alvarez-Elías
Alice Topping
Jochen G Raimann
Guido Filler, Western University
Dalia Yousif
Peter Kotanko
Len A Usvyat
Mara Medeiros
Roberto Pecoits-Filho
Bernard Canaud
Stefano Stuard
Xu Xiaoqi
Michael Etter
Maria E Díaz-González de FerrisFollow

Document Type

Article

Publication Date

11-1-2018

Journal

The Journal of Pediatrics

Volume

202

First Page

171

Last Page

178

URL with Digital Object Identifier

https://doi.org/10.1016/j.jpeds.2018.07.033

Abstract

Objective

We sought to assess worldwide differences among pediatric patients undergoing hemodialysis. Because practices differ widely regarding nutritional resources, treatment practice, and access to renal replacement therapy, investigators from the Pediatric Investigation and Close Collaboration to examine Ongoing Life Outcomes, the pediatric subset of the MONitoring Dialysis Outcomes Cohort (PICCOLO MONDO) performed this cross-sectional study. We hypothesized that growth would be better in developed countries, possibly at the expense of bone mineral disease.

Study Design

In this cross-sectional study, we analyzed growth by height z score and recommended age-specific bone mineral metabolism markers from 225 patientshemodialysis, between the years of 2000 to 2012 from 21 countries in different regions.

Results

The patients' median age was 16 (IQR 14-17) years, and 45% were females. A height z score less than the third percentile was noted in 34% of the cohort, whereas >66% of patients reported normal heights, with patients from North America having the greatest proportion (>80%). More than 70% of the entire cohort had greater than the age-recommended levels of phosphorus, particularly in the Asia-Pacific and North America, where we also observed the greatest body mass index z score (0.99 ± 1.6) and parathyroid hormone levels (557.1 [268.4-740.5]). Below-recommended parathyroid hormone levels were noted in 26% and elevated levels in 61% of the entire sample, particularly in the Asia Pacific region. Lower-than-recommended calcium levels were noted in 36% of the entire cohort, particularly in Latin America.

Conclusions

We found regional differences in growth- and age-adjusted bone mineral metabolism markers. Children from North America had the best growth, received the most dialysis, but also had the worst phosphate control and body mass index z scores.

Notes

Article available at The Journal of Pediatrics

https://doi.org/10.1016/j.jpeds.2018.07.033